Ziyang Shen

819 total citations
40 papers, 620 citations indexed

About

Ziyang Shen is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Ziyang Shen has authored 40 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Cancer Research and 9 papers in Surgery. Recurrent topics in Ziyang Shen's work include Cancer-related molecular mechanisms research (12 papers), Circular RNAs in diseases (7 papers) and MicroRNA in disease regulation (5 papers). Ziyang Shen is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), Circular RNAs in diseases (7 papers) and MicroRNA in disease regulation (5 papers). Ziyang Shen collaborates with scholars based in China, United States and South Korea. Ziyang Shen's co-authors include Rujin Zang, Yankai Xia, Chunxia Du, Weibing Tang, Guanglin Chen, Lei Peng, Hua Xie, Yang Su, Xiaoqun Xu and Hongxing Li and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Ziyang Shen

34 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziyang Shen China 15 442 332 140 49 46 40 620
Denis Delić Germany 16 397 0.9× 230 0.7× 99 0.7× 81 1.7× 33 0.7× 32 624
Tomohiro Suhara Japan 9 334 0.8× 239 0.7× 45 0.3× 41 0.8× 101 2.2× 14 655
Edurne Ramos Spain 8 278 0.6× 184 0.6× 75 0.5× 20 0.4× 48 1.0× 11 485
Xiaoqiang Ding China 10 190 0.4× 200 0.6× 47 0.3× 54 1.1× 37 0.8× 14 411
Shengrong Ouyang China 13 255 0.6× 102 0.3× 47 0.3× 23 0.5× 45 1.0× 34 422
Ning Huangfu China 9 247 0.6× 142 0.4× 56 0.4× 88 1.8× 52 1.1× 26 451
Gang Du China 12 185 0.4× 132 0.4× 89 0.6× 30 0.6× 54 1.2× 22 490
Jiahe Xie China 11 242 0.5× 88 0.3× 99 0.7× 29 0.6× 49 1.1× 14 478
Hanna Kim South Korea 9 327 0.7× 158 0.5× 56 0.4× 20 0.4× 22 0.5× 21 600
Mária Godó Hungary 10 237 0.5× 130 0.4× 43 0.3× 76 1.6× 46 1.0× 18 478

Countries citing papers authored by Ziyang Shen

Since Specialization
Citations

This map shows the geographic impact of Ziyang Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziyang Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziyang Shen more than expected).

Fields of papers citing papers by Ziyang Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziyang Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziyang Shen. The network helps show where Ziyang Shen may publish in the future.

Co-authorship network of co-authors of Ziyang Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Ziyang Shen. A scholar is included among the top collaborators of Ziyang Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziyang Shen. Ziyang Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Ziyang, Zhe Sun, Yunrui Bi, & Zhixin Sun. (2025). A Chaos-Initiated and Adaptive Multi-Guide Control-Based Crayfish Optimization Algorithm for Image Analysis. Symmetry. 17(11). 1940–1940.
2.
Shen, Ziyang, Lanlan Jiang, Xiaojing Xie, et al.. (2025). The effects of vildagliptin on glycemic variability in patients with type 2 diabetes on premixed insulin therapy. Frontiers in Endocrinology. 16. 1508918–1508918. 1 indexed citations
4.
Ma, Jingjing, Yuanyuan Liu, Xia Yin, et al.. (2024). Tirzepatide administration improves cognitive impairment in HFD mice by regulating the SIRT3-NLRP3 axis. Endocrine. 87(2). 486–497. 5 indexed citations
5.
Yin, Xia, Jing Jin, Yaqin Sun, et al.. (2024). Tirzepatide’s role in targeting adipose tissue macrophages to reduce obesity-related inflammation and improve insulin resistance. International Immunopharmacology. 143(Pt 2). 113499–113499. 18 indexed citations
7.
Cao, Haixia, et al.. (2023). CDCA4 interacts with IGF2BP1 to regulate lung adenocarcinoma proliferation via the PI3K/AKT pathway. Thoracic Cancer. 14(8). 724–735. 9 indexed citations
8.
Liu, Jun, Kevin Park, Ziyang Shen, et al.. (2023). Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinoma. Frontiers in Immunology. 14. 1285370–1285370. 9 indexed citations
9.
Shen, Ziyang, et al.. (2022). Therapeutic Strategies for Resectable Stage-IIIA N2 Non–Small Cell Lung Cancer Patients: A Network Meta-Analysis. Clinical Medicine Insights Oncology. 16. 1363230447–1363230447. 2 indexed citations
10.
Li, Cheng, Yu Zhu, Wenzhi Chen, et al.. (2022). Circulating NAD+ Metabolism-Derived Genes Unveils Prognostic and Peripheral Immune Infiltration in Amyotrophic Lateral Sclerosis. Frontiers in Cell and Developmental Biology. 10. 831273–831273. 12 indexed citations
11.
Huang, Rong, Tingting Cai, Yunting Zhou, et al.. (2021). Ethnicity Differences in the Association of UCP1‐3826A/G, UCP2‐866G/A and Ala55Val, and UCP3‐55C/T Polymorphisms with Type 2 Diabetes Mellitus Susceptibility: An Updated Meta‐Analysis. BioMed Research International. 2021(1). 3482879–3482879. 4 indexed citations
12.
Jiang, Zongdan, Jun Wang, Ziyang Shen, Zhenyu Zhang, & Shukui Wang. (2021). Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma. Frontiers in Cellular and Infection Microbiology. 11. 774330–774330. 31 indexed citations
13.
Jiang, Hemin, Yuwei Liu, Yu Q, et al.. (2020). CHL1 promotes insulin secretion and negatively regulates the proliferation of pancreatic β cells. Biochemical and Biophysical Research Communications. 525(4). 1095–1102. 11 indexed citations
14.
Shen, Ziyang, Hemin Jiang, Hsiang‐Ting Hsu, et al.. (2019). MicroRNA-127 inhibits cell proliferation via targeting Kif3b in pancreatic β cells. Aging. 11(5). 1342–1355. 22 indexed citations
15.
Huang, Qiuxiang, Ziyang Shen, Rujin Zang, et al.. (2018). Identification of novel genes and pathways in colorectal cancer exosomes: a bioinformatics study. Translational Cancer Research. 7(3). 651–658. 3 indexed citations
16.
Fu, Qi, Hemin Jiang, Zibin Wang, et al.. (2018). Injury factors alter miRNAs profiles of exosomes derived from islets and circulation. Aging. 10(12). 3986–3999. 36 indexed citations
17.
Chen, Guanglin, Lei Peng, Chunxia Du, et al.. (2017). LncRNA AFAP1-AS Functions as a Competing Endogenous RNA to Regulate RAP1B Expression by sponging miR-181a in the HSCR. International Journal of Medical Sciences. 14(10). 1022–1030. 27 indexed citations
18.
Du, Xin, Markus Karlsson, Yawei Xu, et al.. (2017). GW28-e0740 eHelp China, a randomised trial evaluating the effect of a smart phone-based patient support tool on treatment duration in patients prescribed rosuvastatin in China. Journal of the American College of Cardiology. 70(16). C27–C28. 1 indexed citations
19.
Du, Chunxia, Ziyang Shen, Rujin Zang, et al.. (2016). Negative feedback circuitry between MIR143HG and RBM24 in Hirschsprung disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(11). 2127–2136. 20 indexed citations
20.
Peng, Lei, Guanglin Chen, Ziyang Shen, et al.. (2016). Circular RNA ZNF609 functions as a competitive endogenous RNA to regulate AKT3 expression by sponging miR-150-5p in Hirschsprung's disease. Oncotarget. 8(1). 808–818. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026